Maze Therapeutics, Inc (NASDAQ:MAZE) IPO will take place January, 31 on the NASDAQ exchange under the ticker MAZE.

The company is offering shares at an expected price between $15.00 and $17.00 per share with an insider lock-up period of 180 days ending on July 30, 2025.

See also: Benzinga IPO Calendar

About Maze Therapeutics, Inc

Maze Therapeutics, Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with CVRM diseases, including obesity.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.